Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion type Assertion NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_head.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion description "[Unexpectedly, these drugs did not suppress the growth of BRCA2-deficient pancreatic cancer cell lines from humans or gene-targeted mice expressing active Kras and trans-dominant inhibitory mutant Trp53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion evidence source_evidence_literature NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion SIO_000772 21289082 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion wasDerivedFrom befree-2016 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion wasGeneratedBy ECO_0000203 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.